Replies to post #1964 on Regen BioPharma Inc (RGBP)

[sizzleweed]

I agree Peter. I feel we are 30 days or less from IND. And we have dCellVax to submit, along with Hema II, GLTA RGBP

"We are grateful for the examiners at the FDA to have taken the time to walk us through their thinking and explaining to us what they believe will add the greatest level of safety to our HemaXellerate product. By closely working with the FDA now, we believe the path for future trials, including other disease indications will be much smoother," said Thomas Ichim, PhD, Chief Scientific Officer of Regen BioPharma Inc.